The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate α3β1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gustafson Wagner, Elisabeth ^a   Stipp, Christopher S ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD151 ANTIGEN; CD81 ANTIGEN; PROTEIN KINASE C ALPHA; VERY LATE ACTIVATION ANTIGEN 3;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD151; ANTIGENS, CD81; ANTIGENS, CD9; BREAST NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; CELL SHAPE; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMANS; INTEGRIN ALPHA3BETA1; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; RATS;

EID: 84876249595     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061834     Document Type: Article

References (75)

1. Humphries JD, Byron A, Humphries MJ, (2006) Integrin ligands at a glance. J Cell Sci 119: 3901-3903 doi:10.1242/jcs.03098.
2. Hynes RO, (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
3. Yurchenco PD, (2011) Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol 3doi:10.1101/cshperspect.a004911.
4. Margadant C, Charafeddine RA, Sonnenberg A, (2010) Unique and redundant functions of integrins in the epidermis. FASEB J 24: 4133-4152 doi:10.1096/fj.09-151449.
5. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, et al. (2004) Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 167: 1231-1240 doi:10.1083/jcb.200404100.
6. Stipp CS, (2010) Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med 12: e3 doi:10.1017/S1462399409001355.
7. Wang HX, Li Q, Sharma C, Knoblich K, Hemler ME, (2011) Tetraspanin protein contributions to cancer. Biochem Soc Trans 39: 547-552 doi:10.1042/BST0390547.
8. Zöller M, (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9: 40-55 doi:10.1038/nrc2543.
9. Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F, (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19: 434-446 doi:10.1016/j.tcb.2009.06.004.
10. Charrin S, Le Naour F, Silvie O, Milhiet PE, Boucheix C, et al. (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J 420: 133-154 doi:10.1042/BJ20082422.
11. Hemler ME, (2008) Targeting of tetraspanin proteins- potential benefits and strategies. Nature reviews Drug discovery 7: 747-758 doi:10.1038/nrd2659.
12. Berditchevski F, (2001) Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 114: 4143-4151.
13. Ren B, Yu YP, Tseng GC, Wu C, Chen K, et al. (2007) Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma. J Natl Cancer Inst 99: 868-880 doi:10.1093/jnci/djk199.
14. Ziober BL, Chen YQ, Ramos DM, Waleh N, Kramer RH, (1999) Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ 10: 479-490.
15. Lipscomb EA, Mercurio AM, (2005) Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev 24: 413-423 doi:10.1007/s10555-005-5133-4.
16. Raymond K, Kreft M, Song JY, Janssen H, Sonnenberg A, (2007) Dual Role of alpha6beta4 integrin in epidermal tumor growth: tumor-suppressive versus tumor-promoting function. Mol Biol Cell 18: 4210-4221 doi:10.1091/mbc.E06-08-0720.
17. Owens DM, Romero MR, Gardner C, Watt FM, (2003) Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling. J Cell Sci 116: 3783-3791 doi:10.1242/jcs.00725.
18. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, et al. (2006) Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126: 489-502 doi:10.1016/j.cell.2006.05.047.
19. Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, et al. (2010) The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. J Cell Physiol 224: 283-288 doi:10.1002/jcp.22149.
20. Nagle RB, Cress AE, (2011) Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis. Prostate Cancer 2011: 249290 doi:10.1155/2011/249290.
21. Lamb LE, Zarif JC, Miranti CK, (2011) The Androgen Receptor Induces Integrin {alpha}6{beta}1 to Promote Prostate Tumor Cell Survival via NF-{kappa}B and Bcl-xL Independently of PI3K Signaling. Cancer Res doi:10.1158/0008-5472.CAN-10-2745.
22. Mitchell K, Svenson KB, Longmate WM, Gkirtzimanaki K, Sadej R, et al. (2010) Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res 70: 6359-6367 doi:10.1158/0008-5472.CAN-09-4283.
23. Schmelz M, Cress AE, Scott KM, Bürger F, Cui H, et al. (2002) Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia 4: 243-254 doi:10.1038/sj/neo/7900223.
24. Weitzman JB, Hemler ME, Brodt P, (1996) Reduction of tumorigenicity by alpha 3 integrin in a rhabdomyosarcoma cell line. Cell Adhes Commun 4: 41-52.
25. Owens DM, Watt FM, (2001) Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res 61: 5248-5254.
26. Lamar JM, Pumiglia KM, Dipersio CM, (2008) An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion. Cancer Res 68: 7371-7379 doi:10.1158/0008-5472.CAN-08-1080.
27. Choma DP, Milano V, Pumiglia KM, Dipersio CM, (2007) Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5. J Invest Dermatol 127: 31-40 doi:10.1038/sj.jid.5700505.
28. Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, et al. (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 7: 787-798 doi:10.1158/1541-7786.MCR-08-0574.
29. Subbaram S, Dipersio CM, (2011) Integrin α3β1 as a breast cancer target. Expert Opin Ther Targets 15: 1197-1210 doi:10.1517/14728222.2011.609557.
30. Winterwood NE, Varzavand A, Meland MN, Ashman LK, Stipp CS, (2006) A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5. Mol Biol Cell 17: 2707-2721 doi:10.1091/mbc.E05-11-1042.
31. Zhou H, Kramer RH, (2005) Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. J Biol Chem 280: 10624-10635 doi:10.1074/jbc.M411900200.
32. Gu J, Sumida Y, Sanzen N, Sekiguchi K, (2001) Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-CrkII-DOCK180 pathway. J Biol Chem 276: 27090-27097 doi:10.1074/jbc.M102284200.
33. Frank DE, Carter WG, (2004) Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci 117: 1351-1363 doi:10.1242/jcs.01003.
34. Baldwin G, Novitskaya V, Sadej R, Pochec E, Litynska A, et al. (2008) Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J Biol Chem 283: 35445-35454 doi:10.1074/jbc.M806394200.
35. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, et al. (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68: 3204-3213 doi:10.1158/0008-5472.CAN-07-2949.
36. Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, et al. (2010) Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 70: 6059-6070 doi:10.1158/0008-5472.CAN-09-3497.
37. Yang XH, Mirchev R, Deng X, Yacono P, Yang HL, et al. (2012) CD151 restricts the α6 integrin diffusion mode. J Cell Sci 125: 1478-1487 doi:10.1242/jcs.093963.
38. Stipp CS, Kolesnikova TV, Hemler ME, (2001) EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem 276: 40545-40554 doi:10.1074/jbc.M107338200.
39. Stipp CS, Orlicky D, Hemler ME, (2001) FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein. J Biol Chem 276: 4853-4862 doi:10.1074/jbc.M009859200.
40. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, et al. (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276: 14329-14337 doi:10.1074/jbc.M011297200.
41. Charrin S, Le Naour F, Labas V, Billard M, Le Caer JP, et al. (2003) EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J 373: 409-421 doi:10.1042/BJ20030343.
42. Clark KL, Zeng Z, Langford AL, Bowen SM, Todd SC, (2001) PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. J Immunol 167: 5115-5121.
43. Zevian S, Winterwood NE, Stipp CS, (2011) Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin. Journal of Biological Chemistry 286: 7496-7506 doi:10.1074/jbc.M110.173583.
44. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, et al. (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109: 1524-1532 doi:10.1182/blood-2006-08-041970.
45. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, et al. (1992) Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol 66: 1394-1401.
46. Yauch RL, Berditchevski F, Harler MB, Reichner J, Hemler ME, (1998) Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell 9: 2751-2765.
47. Weitzman JB, Pasqualini R, Takada Y, Hemler ME, (1993) The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem 268: 8651-8657.
48. Schneider CA, Rasband WS, Eliceiri KW, (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
49. Stipp CS, Kolesnikova TV, Hemler ME, (2003) EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5. J Cell Biol 163: 1167-1177 doi:10.1083/jcb.200309113.
50. Zhang XA, Bontrager AL, Hemler ME, (2001) Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 276: 25005-25013 doi:10.1074/jbc.M102156200.
51. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, et al. (2005) Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 15: 1276-1285 doi:10.1016/j.cub.2005.06.043.
52. Yauch RL, Kazarov AR, Desai B, Lee RT, Hemler ME, (2000) Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151. J Biol Chem 275: 9230-9238.
53. Kazarov AR, Yang X, Stipp CS, Sehgal B, Hemler ME, (2002) An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol 158: 1299-1309.
54. Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, et al. (1999) Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 340 (Pt 1):: 103-111.
55. Zevian CS (2011) Structure-Function Analysis of Tetraspanin CD151. University of Iowa PhD Thesis.
56. Zhang XA, Bontrager AL, Stipp CS, Kraeft SK, Bazzoni G, et al. (2001) Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement. Mol Biol Cell 12: 351-365.
57. Deng X, Li Q, Hoff J, Novak M, Yang H, et al. (2012) Integrin-Associated CD151 Drives ErbB2-Evoked Mammary Tumor Onset and Metastasis. Neoplasia 14: 678-689.
58. Li Q, Yang XH, Xu F, Sharma C, Wang HX, et al. (2012) Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene doi:10.1038/onc.2012.205.
59. Nishiuchi R, Sanzen N, Nada S, Sumida Y, Wada Y, et al. (2005) Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci USA 102: 1939-1944 doi:10.1073/pnas.0409493102.
60. Yamada M, Sumida Y, Fujibayashi A, Fukaguchi K, Sanzen N, et al. (2008) The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511. FEBS J 275: 3335-3351 doi:10.1111/j.1742-4658.2008.06481.x.
61. Yang XH, Flores LM, Li Q, Zhou P, Xu F, et al. (2010) Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 70: 2256-2263 doi:10.1158/0008-5472.CAN-09-4032.
62. Powner D, Kopp PM, Monkley SJ, Critchley DR, Berditchevski F, (2011) Tetraspanin CD9 in cell migration. Biochem Soc Trans 39: 563-567 doi:10.1042/BST0390563.
63. Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R, Salazar EP, (2010) Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol 89: 843-852 doi:10.1016/j.ejcb.2010.07.004.
64. Pellinen T, Rantala JK, Arjonen A, Mpindi JP, Kallioniemi O, et al. (2012) A functional genetic screen reveals new regulators of β1-integrin activity. J Cell Sci 125: 649-661 doi:10.1242/jcs.090704.
65. Quast T, Eppler F, Semmling V, Schild C, Homsi Y, et al. (2011) CD81 is essential for the formation of membrane protrusions and regulates Rac1-activation in adhesion-dependent immune cell migration. Blood 118: 1818-1827 doi:10.1182/blood-2010-12-326595.
66. Kohmo S, Kijima T, Otani Y, Mori M, Minami T, et al. (2010) Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res 70: 8025-8035 doi:10.1158/0008-5472.CAN-10-0996.
67. Cailleteau L, Estrach S, Thyss R, Boyer L, Doye A, et al. (2010) alpha2beta1 integrin controls association of Rac with the membrane and triggers quiescence of endothelial cells. J Cell Sci 123: 2491-2501 doi:10.1242/jcs.058875.
68. Takeda Y, He P, Tachibana I, Zhou B, Miyado K, et al. (2008) Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem 283: 26089-26097 doi:10.1074/jbc.M801902200.
69. Chang Y, Finnemann SC, (2007) Tetraspanin CD81 is required for the alpha v beta5-integrin-dependent particle-binding step of RPE phagocytosis. J Cell Sci 120: 3053-3063 doi:10.1242/jcs.006361.
70. Furuya M, Kato H, Nishimura N, Ishiwata I, Ikeda H, et al. (2005) Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets. Cancer Res 65: 2617-2625 doi:10.1158/0008-5472.CAN-04-3123.
71. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S, (2005) A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 280: 35545-35553 doi:10.1074/jbc.M505630200.
72. García-López MA, Barreiro O, García-Díez A, Sánchez-Madrid F, Peñas PF, (2005) Role of tetraspanins CD9 and CD151 in primary melanocyte motility. J Invest Dermatol 125: 1001-1009 doi:10.1111/j.0022-202X.2005.23882.x.
73. Kim J, Thorne SH, Sun L, Huang B, Mochly-Rosen D, (2011) Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model. Oncogene 30: 323-333 doi:10.1038/onc.2010.415.
74. Lønne GK, Cornmark L, Zahirovic IO, Landberg G, Jirström K, et al. (2010) PKCalpha expression is a marker for breast cancer aggressiveness. Mol Cancer 9: 76 doi:10.1186/1476-4598-9-76.
75. Jiang Y, Berk M, Singh LS, Tan H, Yin L, et al. (2005) KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 22: 369-376 doi:10.1007/s10585-005-8186-4.